An in vitro urinary tract catheter system to investigate biofilm development in catheter-associated urinary tract infections

Journal of Microbiological Methods

Volumn 87, Issue 3, 2011, Pages 302-308

  Dohnt, Katrin ^a   Sauer, Marie ^a   Müller, Maren ^a   Atallah, Karin ^a   Weidemann, Marina ^a   Gronemeyer, Petra ^a   Rasch, Detlev ^a   Tielen, Petra ^a   Krull, Rainer ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Biofilm cultivation system; Catheter associated urinary tract infection; In vitro urinary tract catheter system; Pseudomonas aeruginosa

Indexed keywords

SILICONE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; BALLOON CATHETER; BIOFILM; BIOFILM REACTOR; BIOSENSOR; CATHETER INFECTION; CELL SURFACE; CONTROLLED STUDY; DISEASE ASSOCIATION; GROWTH RATE; HYDROPHOBICITY; IN VITRO STUDY; MICROBIAL BIOMASS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; URINALYSIS; URINARY CATHETER; URINARY TRACT INFECTION; URINE VOLUME;

ADULT; BIOFILMS; CATHETERS; HUMANS; PSEUDOMONAS AERUGINOSA; URINARY TRACT INFECTIONS;

PSEUDOMONAS AERUGINOSA;

EID: 81055156746     PISSN: 01677012     EISSN: 18728359     Source Type: Journal    
DOI: 10.1016/j.mimet.2011.09.002     Document Type: Article

References (47)

1. Anwar H., Strap J., Costeron J. Establishing of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob. Agents Chemother. 1992, 36:1347-1351.
2. Azevedo N., Lopes S., Keevil C., Pereira M., Vieira M. Time to "go large" on biofilm research advantages of an omics approach. Biotechnol. Lett. 2009, 31:477-485.
3. Banks M., Bryers J. Bacterial species dominance within a binary culture biofilm. Appl. Environ. Microbiol. 1991, 57:1974-1979.
4. Bester E., Wolfaardt G., Joubert L., Garny K., Saftic S. Planktonic-cell yield of a Pseudomonad biofilm. Appl. Environ. Microbiol. 2005, 71:7792-7798.
5. Billote-Domingo K., Mendoza M., Torres T. Catheter-related urinary tract infections: incidence, risk factors and microbiologic profile. Phil. J. Microbiol. Infect. Dis. 1999, 28:133-138.
6. Brooks T., Keevil C. A simple artificial urine for the growth of urinary pathogens. Lett. Appl. Microbiol. 1997, 24:203-206.
7. Characklis W. Bioengineering report: fouling biofilm development: a process analysis. Biotechnol. Bioeng. 1981, 23:1923-1960.
8. Costerton J. Introduction to biofilm. Int. J. Antimicrob. Agents 1999, 11:217-221.
9. Dohnt, K., 2011. Charakterisierung von PSeudomonas aeruginosa-Biofilmen in einem in vitro-Harnwegskathetersystem. In: IBVT-Schriftenreihe, Vol. 61, Cuvillier-Verlag, Göttingen.
10. Edlich A., Magdanz V., Rasch D., Demming S., Zadeh S.A., Segura R., Kähler C., Radespiel R., Büttgenbach S., Franco-Lara E., Krull R. Microfluidic reactor for continuous cultivaton of Saccharomyces cerevisiae. Biotechnol. Prog. 2010, 26:1259-1270.
11. Friedman L., Kolter R. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol. Microbiol. 2004, 51:674-690.
12. Friedman L., Kolter R. Two genetic loci produce distinct carbohydrate -rich structural components of the Pseudomonas aeruginsoa biofilm matrix. J. Bacteriol. 2004, 186:4457-4465.
13. Ganderton J., Chawla J., Winters C., Wimpeny J., Stickler D. Scanning electron microscopy of bacterial biofilms on indwelling catheters. Eur. J. Clin. Microbiol. Infect. Dis. 1992, 11:789-796.
14. Gilmore B., Hamill T., Jones D., Gorman S. Validation of the CDC biofilm reactor as a dynamic model for assessment of encrustation formation on urological device materials. J. Biomed. Mater. Res. B 2010, 93B:128-140.
15. Gristina A. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 1987, 237:1588-1595.
16. Haley R., Culver D., White J., Morgan W., Emor T. The nationwide nosocomial infection rate. Am. J. Epidemiol. 1985, 121:159-167.
17. Head N., Yu H. Cross-sectional analysis of clinical environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity. Infect. Immun. 2004, 72:133-144.
18. Horn H., Hempel D. Growth and decay in an auto-/heterotrophic biofilm. Water Res. 1997, 31:2243-2252.
19. Horn H., Wulkow M. Modellierung von Einleitungen in kleine Fließgewässer. Gwf Wasser Abwasser. 1996, 137:557-564.
20. Jackson K., Starkey M., Kremer S., Parsek M., Wozniak D. Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J. Bacteriol. 2004, 186:4466-4475.
21. Keevil C. The value of in situ Biofilm Investigations. The Life and Death of Biofilm 1995, 17-20. BioLine, Cardiff.
22. Körstgens V., Flemming H.-C., Wingender J., Borchard W. Influence of Calcium ions in the mechanical properties of a model biofilm of mucoid Pseudomonas aeruginosa. Water Sci. Technol. 2001, 43:49-57.
23. Kumon H. Pathogenesis and management of bacterial biofilms in the urinary tract. J. Infect. Chemother. 1996, 2:18-28.
24. Marthur S., Suller M., Stickler D., Feneley R. Factors affecting crystal precipitation from urine in individuals with long-term urinary catheters colonized with urease-positive bacterial spezies. Urol. Res. 2006, 34:173-177.
25. Mears E. Current patterns in nosocomial urinary tract infections. Urology 1991, 37:9-12.
26. Merrit J., Kadourim D., OD́Toole G. Growing and analyzing static biofilms. Current Protocols in Microbiology 2005, John Wiley & Son, Inc, 1B.1.1.- 1B.1.17.
27. Ng F.M., Dawes E.A. Chemostat studies on the regulation of glucose metabolism in Pseudomonas aeruginosa by citrate. Biochem. J. 1973, 132:129-140.
28. Nickel J., Ruseska I., Wright J., Costerton J. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter materials. Antimicrob. Agents Chemother. 1985, 27:619-624.
29. Pschyrembel W.H. Klinisches Wörterbuch 2001, Walter de Gruyter, Berlin. 259 Edition.
30. Purevdorj B., Costerton J.W., Stoodley P. Influence of hydrodynamics and cell signaling on the structure and behaviour of Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol. 2002, 68:4457-4464.
31. Rahme L.G., Tan M.W., Le L., Wong A.M., Tompkins R.G., Calderwood S.B., Ausubel F.M. Use of model plant host to identify Pseudomonas aeruginosa virulence factors. Proc. Natl Acad. Sci. USA 1997, 94:13245-13250.
32. Reid G. Biofilms in infectious disease and on medical devices. Int. J. Antimicrob. Agents 1999, 11:223-226.
33. Rogers J., Norkett D.I., Bracegirdle P., Dowsett A.B., Walker J.T., Brooks T., Keevil C.W. Examination of biofilm formation and risk of infection associated with the use of urinary catheters with leg bags. J. Hosp. Infect. 1996, 32:105-115.
34. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens, disease monitoring. Am. J. Med. 2002, 49:71-82.
35. Safdar N., Crnich C.J., Mak D.G. Nosocomial infections in the intensive care unit associated with invasive medical devices. Curr. Infect. Dis. Rep. 2001, 3:487-495.
36. Stamm W.E. Catheter-associated urinary tract infections: epidemiology, pathogenesis, and prevention. Am. J. Med. 1991, 91:65S-71S.
37. Stapper A., Narasinhan G., Ohman G., Barakat J., Hentzer M., Molin S., Kharazmi A., Hoiby N., Mathee K. Alginate production affects Pseudomonas aeruginosa development and architecture but is not essential for biofilm formation. J. Med. Microbiol. 2004, 53:679-690.
38. Staudt C., Horn H., Hempel D.C., Neu T.R. Volumetric Measurements of bacterial cells and extracellular polymeric substance glycoconjugates in biofilms. Biotechnol. Bioeng. 2004, 88:585-592.
39. Stickler D.J. Bacterial biofilms and the encrustation of urethral catheters. Biofouling 1996, 9:293-305.
40. Thomas L. Labor und Diagnose: Identifikation und Bewertung von Laborfunden für die medizinische Diagnostik 1988, Medizinische Verlagsgesellschaft, Marburg. 3. Auflage.
41. Tielen P., Narten M., Rosin N., Biegler I., Haddad I., Hogardt M., Neubauer R., Schobert M., Wiehlmann L., Jahn D. Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections. Int. J. Med. Microbiol. 2010, 156:2239-2252.
42. Tunney M., Jones D., Gorman S. Biofilm and biofilm-related encrustation of urinary tract devices. Methods in Enzymology 1999, Vol. 310:558-566. Academic Press, San Diego.
43. Warren J.W. Catheter-associated urinary tract infections. Infect. Dis. Clin. N. Am. 1997, 11:609-622.
44. Wäsche S., Horn H., Hempel D. Influence of growth conditions on biofilm development and mass transfer at the bulk/ biofilm interface. Water Res. 2002, 36:4775-4784.
45. Wolff J., Hooper D. Isolation and Characterization of Catabolite Repression Control Mutants of Pseudomonas aeruginosa PAO. J. Bacteriol. 1985, 173:4700-4706.
46. Wozniak D., Wyckoff T., Starkey M., Keyser R., Azadi P., Toole G., Parsek M. Algiante is not a significant component of the extracellular polysaccharide matrix PA14 and PAO1 Pseudomonas aeruginosa biofilms. Proc. Natl Acad. Sci. USA 2003, 100:7907-7912.
47. Yang L., Haagensen J.A.J., Jelsbak L., Johanson H.K., Sternberg C., Hoiby N., Molin S. In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J. Bacteriol. 2008, 190:2767-2776.